MedPath
HSA Approval

AMCAD 5 TABLET 5 mg

SIN14529P

AMCAD 5 TABLET 5 mg

AMCAD 5 TABLET 5 mg

March 27, 2014

UNI DRUG HOUSE

UNI DRUG HOUSE

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantUNI DRUG HOUSE
Licence HolderUNI DRUG HOUSE

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

C08CA01

amlodipine

Manufacturer Information

UNI DRUG HOUSE SDN. BHD.

CADILA PHARMACEUTICALS LIMITED

Active Ingredients

Amlodipine Besilate 6.9335 mg eqv. to Amlodipine

5 mg

Amlodipine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

AMCAD 5 TABLET 5 mg - HSA Approval | MedPath